S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
OTCMKTS:SOMMY

Sumitomo Chemical - SOMMY Stock Forecast, Price & News

$20.32
+0.02 (+0.10%)
(As of 08/9/2022 04:35 PM ET)
Add
Compare
Today's Range
$20.23
$20.49
50-Day Range
$18.19
$21.03
52-Week Range
$17.63
$27.99
Volume
34,979 shs
Average Volume
37,247 shs
Market Capitalization
$6.73 billion
P/E Ratio
5.00
Dividend Yield
1.97%
Price Target
N/A
SOMMY stock logo

About Sumitomo Chemical (OTCMKTS:SOMMY) Stock

Sumitomo Chemical Company, Limited engages in the petrochemicals and plastics, energy and functional materials, IT-related chemicals, health and crop sciences, pharmaceuticals, and other businesses worldwide. Its Petrochemicals & Plastics segment offers synthetic resins, such as polyethylene, polypropylene, and polymethyl methacrylate resins; raw materials for synthetic fibers; and various industrial chemicals. The company's Energy & Functional Materials segment provides alumina and aluminum products used for energy products; polymer additives and rubber chemicals; synthetic rubber for tires, shoes, construction materials, and other applications; and engineering plastics and lithium-ion secondary battery materials for use in electronic components and next-generation vehicles. Its IT-Related Chemicals segment provides polarizing films, touch screen sensor panels, and color resists for LC and OLED displays; photoresists and high-purity chemicals for semiconductor manufacturing process; and compound semiconductor materials for antenna switches and other components of communication terminal equipment. The company's Health & Crop Sciences segment offers crop protection chemicals, fertilizers, feed additives, and household insecticides; active pharmaceutical ingredients and intermediates; and products to control infectious diseases. Its Pharmaceuticals segment provides prescription and diagnostic pharmaceuticals. The company's Others segment supplies electric power and steam; designs, constructs, and supervises chemical plants; provides transportation and warehousing services; and conducts physical property and environmental analysis. It has collaboration with Ginkgo Bioworks Announces Sumitomo Chemical to develop bio-based chemicals. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.

Receive SOMMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sumitomo Chemical and its competitors with MarketBeat's FREE daily newsletter.

SOMMY Stock News Headlines

Sumitomo Chemical Company, Limited (SOMMY)
Sumitomo Chemical earnings: here's what Wall Street expects
Sumitomo Chemical Co Ltd ADR (SOMMY)
Sumitomo Chemical Co Ltd
Sumitomo Chemical Co. Ltd. ADR
Sumitomo Chemical Company Limited ADR (SOMMY)
See More Headlines
Receive SOMMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sumitomo Chemical and its competitors with MarketBeat's FREE daily newsletter.

SOMMY Company Calendar

Last Earnings
5/13/2022
Today
8/09/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:SOMMY
Employees
34,743
Year Founded
N/A

Profitability

Net Income
$1.32 billion
Pretax Margin
9.08%

Debt

Sales & Book Value

Annual Sales
$22.59 billion
Cash Flow
$8.00 per share
Book Value
$42.00 per share

Miscellaneous

Free Float
N/A
Market Cap
$6.73 billion
Optionable
Not Optionable
Beta
0.81

Key Executives

  • Mr. Keiichi Iwata (Age 65)
    Pres & Representative Director
    Comp: $813.36k
  • Keigo Sasaki
    Managing Exec. Officer of Accounting, Fin. & Corp. Communications Dept.
  • Mr. Hiroshi Ueda (Age 66)
    Exec. VP & Director
  • Mr. Hiroshi Niinuma (Age 64)
    Exec. VP & Director
  • Mr. Noriaki Takeshita (Age 64)
    Sr. Managing Exec. Officer & Representative Director
  • Mr. Marc Vermeire
    Managing Exec. Officer
  • Mr. Takashi Shigemori (Age 64)
    Sr. Managing Exec. Officer
  • Mr. Masaki Matsui (Age 62)
    Sr. Managing Exec. Officer & Representative Director
  • Mr. Keiichi Sakata (Age 63)
    Managing Exec. Officer
  • Motoyuki Sakai (Age 61)
    Managing Exec. Officer













SOMMY Stock - Frequently Asked Questions

Should I buy or sell Sumitomo Chemical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sumitomo Chemical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SOMMY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SOMMY, but not buy additional shares or sell existing shares.
View SOMMY analyst ratings
or view top-rated stocks.

How has Sumitomo Chemical's stock performed in 2022?

Sumitomo Chemical's stock was trading at $23.58 at the start of the year. Since then, SOMMY stock has decreased by 13.8% and is now trading at $20.32.
View the best growth stocks for 2022 here
.

Are investors shorting Sumitomo Chemical?

Sumitomo Chemical saw a decrease in short interest during the month of July. As of July 15th, there was short interest totaling 48,500 shares, a decrease of 16.8% from the June 30th total of 58,300 shares. Based on an average daily trading volume, of 64,700 shares, the short-interest ratio is presently 0.7 days.
View Sumitomo Chemical's Short Interest
.

How were Sumitomo Chemical's earnings last quarter?

Sumitomo Chemical Company, Limited (OTCMKTS:SOMMY) announced its quarterly earnings data on Friday, May, 13th. The company reported $0.49 earnings per share (EPS) for the quarter. The firm had revenue of $4 million for the quarter. Sumitomo Chemical had a trailing twelve-month return on equity of 9.53% and a net margin of 7.48%.

Is Sumitomo Chemical a good dividend stock?

Sumitomo Chemical (OTCMKTS:SOMMY) pays an annual dividend of $0.40 per share and currently has a dividend yield of 1.97%. The dividend payout ratio is 9.85%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Sumitomo Chemical's stock symbol?

Sumitomo Chemical trades on the OTCMKTS under the ticker symbol "SOMMY."

How do I buy shares of Sumitomo Chemical?

Shares of SOMMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sumitomo Chemical's stock price today?

One share of SOMMY stock can currently be purchased for approximately $20.32.

How much money does Sumitomo Chemical make?

Sumitomo Chemical (OTCMKTS:SOMMY) has a market capitalization of $6.73 billion and generates $22.59 billion in revenue each year. The company earns $1.32 billion in net income (profit) each year or $4.06 on an earnings per share basis.

How many employees does Sumitomo Chemical have?

Sumitomo Chemical employs 34,743 workers across the globe.

How can I contact Sumitomo Chemical?

Sumitomo Chemical's mailing address is 27-1 Shinkawa 2-chome, Tokyo M0, 104-8260. The official website for the company is www.sumitomo-chem.co.jp. The company can be reached via phone at (135) 543-5500 or via fax at 813-5543-5901.

This page (OTCMKTS:SOMMY) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.